| The landscape of metastatic progression patterns across major human cancers J Budczies, M von Winterfeld, F Klauschen, M Bockmayr, JK Lennerz, ... Oncotarget 6 (1), 570, 2014 | 305 | 2014 |
| Prognostic impact of programmed cell death-1 (PD-1) and PD-ligand 1 (PD-L1) expression in cancer cells and tumor-infiltrating lymphocytes in ovarian high grade serous carcinoma S Darb-Esfahani, CA Kunze, H Kulbe, J Sehouli, S Wienert, J Lindner, ... Oncotarget 7 (2), 1486, 2015 | 285 | 2015 |
| Scoring of tumor-infiltrating lymphocytes: From visual estimation to machine learning F Klauschen, KR Müller, A Binder, M Bockmayr, M Hägele, P Seegerer, ... Seminars in cancer biology 52, 151-157, 2018 | 174 | 2018 |
| Resolving challenges in deep learning-based analyses of histopathological images using explanation methods M Hägele, P Seegerer, S Lapuschkin, M Bockmayr, W Samek, ... Scientific reports 10 (1), 6423, 2020 | 172 | 2020 |
| Morphological and molecular breast cancer profiling through explainable machine learning A Binder, M Bockmayr, M Hägele, S Wienert, D Heim, K Hellweg, M Ishii, ... Nature Machine Intelligence 3 (4), 355-366, 2021 | 157 | 2021 |
| Classical pathology and mutational load of breast cancer–integration of two worlds J Budczies, M Bockmayr, C Denkert, F Klauschen, JK Lennerz, B Györffy, ... The Journal of Pathology: Clinical Research 1 (4), 225-238, 2015 | 133 | 2015 |
| Machine learning analysis of DNA methylation profiles distinguishes primary lung squamous cell carcinomas from head and neck metastases P Jurmeister, M Bockmayr, P Seegerer, T Bockmayr, D Treue, ... Science Translational Medicine 11 (509), eaaw8513, 2019 | 128 | 2019 |
| Pan‐cancer analysis of copy number changes in programmed death‐ligand 1 (PD‐L1, CD274)–associations with gene expression, mutational load, and survival J Budczies, M Bockmayr, C Denkert, F Klauschen, S Gröschel, ... Genes, Chromosomes and Cancer 55 (8), 626-639, 2016 | 106 | 2016 |
| Subgroup-specific immune and stromal microenvironment in medulloblastoma M Bockmayr, M Mohme, F Klauschen, B Winkler, J Budczies, S Rutkowski, ... Oncoimmunology 7 (9), e1462430, 2018 | 105 | 2018 |
| Atypical teratoid/rhabdoid tumors (ATRTs) with SMARCA4 mutation are molecularly distinct from SMARCB1-deficient cases D Holdhof, PD Johann, M Spohn, M Bockmayr, S Safaei, P Joshi, ... Acta neuropathologica 141, 291-301, 2021 | 79 | 2021 |
| Artificial intelligence and pathology: from principles to practice and future applications in histomorphology and molecular profiling A Stenzinger, M Alber, M Allgäuer, P Jurmeister, M Bockmayr, J Budczies, ... Seminars in cancer biology 84, 129-143, 2022 | 71 | 2022 |
| PD-L1 (CD274) copy number gain, expression, and immune cell infiltration as candidate predictors for response to immune checkpoint inhibitors in soft-tissue sarcoma J Budczies, G Mechtersheimer, C Denkert, F Klauschen, SS Mughal, ... Oncoimmunology 6 (3), e1279777, 2017 | 61 | 2017 |
| Multilayered omics-based analysis of a head and neck cancer model of cisplatin resistance reveals intratumoral heterogeneity and treatment-induced clonal selection F Niehr, T Eder, T Pilz, R Konschak, D Treue, F Klauschen, M Bockmayr, ... Clinical Cancer Research 24 (1), 158-168, 2018 | 56 | 2018 |
| Food authentication: Multi-elemental analysis of white asparagus for provenance discrimination B Richter, S Gurk, D Wagner, M Bockmayr, M Fischer Food chemistry 286, 475-482, 2019 | 54 | 2019 |
| New network topology approaches reveal differential correlation patterns in breast cancer M Bockmayr, F Klauschen, B Györffy, C Denkert, J Budczies BMC systems biology 7, 1-14, 2013 | 53 | 2013 |
| DNA methylation-based classification of sinonasal tumors P Jurmeister, S Glöß, R Roller, M Leitheiser, S Schmid, LH Mochmann, ... Nature Communications 13 (1), 7148, 2022 | 49 | 2022 |
| Toward explainable artificial intelligence for precision pathology F Klauschen, J Dippel, P Keyl, P Jurmeister, M Bockmayr, A Mock, ... Annual Review of Pathology: Mechanisms of Disease 19 (1), 541-570, 2024 | 47 | 2024 |
| Mutation patterns in genes encoding interferon signaling and antigen presentation: A pan‐cancer survey with implications for the use of immune checkpoint inhibitors J Budczies, M Bockmayr, F Klauschen, V Endris, S Fröhling, ... Genes, Chromosomes and Cancer 56 (8), 651-659, 2017 | 44 | 2017 |
| Mutations in genes encoding PI3K‐AKT and MAPK signaling define anogenital papillary hidradenoma N Pfarr, HP Sinn, F Klauschen, C Flechtenmacher, M Bockmayr, ... Genes, Chromosomes and Cancer 55 (2), 113-119, 2016 | 39 | 2016 |
| Single-cell gene regulatory network prediction by explainable AI P Keyl, P Bischoff, G Dernbach, M Bockmayr, R Fritz, D Horst, N Blüthgen, ... Nucleic Acids Research 51 (4), e20-e20, 2023 | 38 | 2023 |
